Current Developments in Intraspinal Agents for Cancer and Noncancer Pain

Since the late 1980s, intrathecal (IT) analgesic therapy has improved, and implantable IT drug delivery devices have become increasingly sophisticated. Physicians and patients now have myriad more options for agents and their combination, as well as for refining their delivery. As recently as 2007,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawson, Erin F., Wallace, Mark S.
Formato: Texto
Lenguaje:English
Publicado: Current Science Inc. 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826634/
https://www.ncbi.nlm.nih.gov/pubmed/20425209
http://dx.doi.org/10.1007/s11916-009-0092-z
_version_ 1782177871747350528
author Lawson, Erin F.
Wallace, Mark S.
author_facet Lawson, Erin F.
Wallace, Mark S.
author_sort Lawson, Erin F.
collection PubMed
description Since the late 1980s, intrathecal (IT) analgesic therapy has improved, and implantable IT drug delivery devices have become increasingly sophisticated. Physicians and patients now have myriad more options for agents and their combination, as well as for refining their delivery. As recently as 2007, The Polyanalgesic Consensus Conference of expert panelists updated its algorithm for drug selection in IT polyanalgesia. We review this algorithm and the emerging therapy included. This article provides an update on newly approved as well as emerging IT agents and the advances in technology for their delivery.
format Text
id pubmed-2826634
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Current Science Inc.
record_format MEDLINE/PubMed
spelling pubmed-28266342010-03-05 Current Developments in Intraspinal Agents for Cancer and Noncancer Pain Lawson, Erin F. Wallace, Mark S. Curr Pain Headache Rep Article Since the late 1980s, intrathecal (IT) analgesic therapy has improved, and implantable IT drug delivery devices have become increasingly sophisticated. Physicians and patients now have myriad more options for agents and their combination, as well as for refining their delivery. As recently as 2007, The Polyanalgesic Consensus Conference of expert panelists updated its algorithm for drug selection in IT polyanalgesia. We review this algorithm and the emerging therapy included. This article provides an update on newly approved as well as emerging IT agents and the advances in technology for their delivery. Current Science Inc. 2010-01-16 2010 /pmc/articles/PMC2826634/ /pubmed/20425209 http://dx.doi.org/10.1007/s11916-009-0092-z Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Lawson, Erin F.
Wallace, Mark S.
Current Developments in Intraspinal Agents for Cancer and Noncancer Pain
title Current Developments in Intraspinal Agents for Cancer and Noncancer Pain
title_full Current Developments in Intraspinal Agents for Cancer and Noncancer Pain
title_fullStr Current Developments in Intraspinal Agents for Cancer and Noncancer Pain
title_full_unstemmed Current Developments in Intraspinal Agents for Cancer and Noncancer Pain
title_short Current Developments in Intraspinal Agents for Cancer and Noncancer Pain
title_sort current developments in intraspinal agents for cancer and noncancer pain
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826634/
https://www.ncbi.nlm.nih.gov/pubmed/20425209
http://dx.doi.org/10.1007/s11916-009-0092-z
work_keys_str_mv AT lawsonerinf currentdevelopmentsinintraspinalagentsforcancerandnoncancerpain
AT wallacemarks currentdevelopmentsinintraspinalagentsforcancerandnoncancerpain

Ejemplares similares